August 7, 2015
Gibson, Dunn & Crutcher LLP is pleased to announce that Jane M. Love, Ph.D. and Robert Trenchard are joining the New York office as partners. Love and Trenchard, previously partners with Wilmer Hale, will continue to practice intellectual property and life sciences litigation.
"We are pleased to welcome Jane and Bob to the firm," said Ken Doran, Chairman and Managing Partner of Gibson Dunn. "Our patent litigation practice is thriving, and adding capacity to the practice to meet client demand, particularly in the life sciences area, is a key goal of the firm. Jane and Bob are highly regarded in the pharmaceutical and biotech sectors, and their additions will strengthen and diversify our IP group."
"We are delighted to bring Jane and Bob on board," said Mark Kirsch, Co-Partner in Charge of the New York office. "Jane is a nationally recognized IP practitioner and Bob is a top-flight complex commercial litigator who has extensive patent litigation experience. They will be strong additions to the firm."
"Jane and Bob bring broad experience and recognized expertise, having successfully handled many important matters for the pharmaceutical and biotech industries, including significant ANDA litigation on behalf of leading pharmaceutical companies," said Josh Krevitt, Co-Chair of the firm’s Intellectual Property Practice Group. "We are thrilled to be able to add Jane and Bob to our deep roster of IP and Life Sciences litigators."
"The firm has a dynamic and robust intellectual property practice, combined with a leading global platform," said Love. "I am excited to be able to contribute to the firm’s expansion of its IP and life sciences practices."
"This is a great opportunity," Trenchard said. "Gibson Dunn is home to a preeminent litigation practice, and I look forward to practicing with my new colleagues."
About Jane M. Love, Ph.D.
Love practices IP and patent litigation, with an emphasis on life sciences and pharmaceutical-related cases. She has extensive experience in biotechnology and chemistry patent issues, including Abbreviated New Drug Application (ANDA) litigation, Biologics Price Competition and Innovation Act of 2009 (BPCIA) litigation and biologics litigation, and advises on biosimilars and post-grant proceedings under the America Invents Act (AIA). She also advises on patent prosecution, patent interferences and reexaminations, and further provides strategic patent portfolio advice and diligence. She is experienced in a wide variety of medical technology, such as pharmaceuticals, antibodies, vaccines, medical devices, small interfering RNA (siRNA), diagnostics, bioinformatics and nanotechnology.
She has practiced with Wilmer Hale since 2001 and served as Co-Vice Chair of that firm’s IP practice. Before practicing law, Love conducted doctoral research at the University of Pennsylvania and Thomas Jefferson Medical School in Philadelphia and post-doctoral research at Cornell University Weill Medical College in New York City in molecular biology, pharmacology and cell and developmental biology. She served as a Captain in the U.S. Army Reserve Medical Service Corp from 1991 to 1997.
She received her law degree from Fordham University School of Law in 1999. She received her Ph.D. in molecular biology from the University of Pennsylvania in 1993.
About Robert Trenchard
Trenchard has 20 years of experience in life sciences and patent litigation and large, complex litigation in a broad range of areas, including securities, antitrust, bankruptcy, commodities regulation, insurance, torts, telecommunications and contract disputes. He has represented corporate and individual clients in high-profile government investigations, in complex civil and regulatory matters in federal and state courts and before regulatory agencies and in international arbitrations.
Before joining the firm, he practiced with Wilmer Hale since 2003. He served as a clerk to Judge Lewis A. Kaplan in U.S. District Court for the Southern District of New York. He graduated cum laude from Harvard Law School in 1994.